Anastrozole in Treating Postmenopausal Women With DCIS or Stage I-III Breast Cancer

Completed · Phase 2

Conditions studied: Breast Cancer

In brief

RATIONALE: Estrogen can cause the growth of breast cancer cells. Hormone therapy using anastrozole may fight breast cancer by lowering the amount of estrogen the body makes. PURPOSE: This phase II trial is studying how anastrozole effects postmenopausal women who have undergone surgery for ductal carcinoma in situ or stage I, stage II, or stage III breast cancer.

Key facts

Study ID

NCT00244959

Run by

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

People needed

54

Starts

2004-01-01

Expected to finish

2011-11-01

Last updated by the study team

2013-03-19

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

Where it is running

• Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.